Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gynecological Cancers”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Large-scale testing (Phase 3)Study completedNCT00850772
What this trial is testing

Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Queensland Centre for Gynaecological Cancer 109
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Early research (Phase 1)Study completedNCT02978755
What this trial is testing

First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

Who this might be right for
Neoplasm, Gynecologic
GamaMabs Pharma 78
Testing effectiveness (Phase 2)Study completedNCT03073525
What this trial is testing

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

Who this might be right for
Advanced Gynecological CancersOvarian CancerCervical Cancer+1 more
Gradalis, Inc. 25
Testing effectiveness (Phase 2)Ended earlyNCT04493619
What this trial is testing

PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer

Who this might be right for
Gynecologic NeoplasmsEpithelial Ovarian Cancer
Opna Bio LLC 37
Testing effectiveness (Phase 2)Study completedNCT04870177
What this trial is testing

Study of AK112 in the Treatment of Advanced Gynecological Tumors

Who this might be right for
Gynecologic CancerCancer MetastaticOvarian Neoplasms+2 more
Akeso 53
Early research (Phase 1)Study completedNCT01831089
What this trial is testing

Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerGynecological Cancer+4 more
PharmaMar 69
Very early researchLooking for participantsNCT06834542
What this trial is testing

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

Who this might be right for
Adult Gynecological Tumors
Grit Biotechnology 26
Not applicableLooking for participantsNCT02906943
What this trial is testing

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Who this might be right for
Breast CancerLung CancerColorectal Cancer+8 more
University Health Network, Toronto 10,000
Not applicableLooking for participantsNCT04957511
What this trial is testing

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Who this might be right for
Gynecologic CancerImmunotherapyGut Microbiome
Viome 30
Testing effectiveness (Phase 2)Looking for participantsNCT06654440
What this trial is testing

A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

Who this might be right for
Advanced Gynecological Malignancy
Shanghai Hengrui Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT01482715
What this trial is testing

Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+1 more
pharmaand GmbH 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07311538
What this trial is testing

Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies

Who this might be right for
Advanced Gynecological Malignancies
BioRay Pharmaceutical Co., Ltd. 56
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Testing effectiveness (Phase 2)Study completedNCT01079832
What this trial is testing

Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

Who this might be right for
Fallopian Tube CancerOvarian SarcomaOvarian Stromal Cancer+23 more
Case Comprehensive Cancer Center 50
Not applicableStudy completedNCT02172638
What this trial is testing

Postoperatory Recovery in Advanced Ovarian Cancer, Fast-Track Protocol vs. Classical Management

Who this might be right for
Median Length of StayReadmission RateSurgery Related Complications Rate+1 more
Hospital Universitari Vall d'Hebron Research Institute 110
Not applicableActive Not RecruitingNCT01505400
What this trial is testing

Integrated Molecular Profiling in Advanced Cancers Trial

Who this might be right for
Breast CancerNon-small Cell Lung CancerColorectal Cancer+7 more
University Health Network, Toronto 3,026
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05152797
What this trial is testing

Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer

Who this might be right for
Tumor Infiltrating Lymphocytes
Women's Hospital School Of Medicine Zhejiang University 91
Early research (Phase 1)Looking for participantsNCT06130254
What this trial is testing

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Who this might be right for
Advanced Solid TumorNon-small Cell Lung Cancers
M.D. Anderson Cancer Center 52
Load More Results